Dealing in securities AfroCentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 (“AfroCentric” or “the Company” or “the Group”) Dealing in Securities by Directors, the Company Secretary and Directors of Major Subsidiaries In compliance with the terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements, the Company hereby discloses the following director’s dealings in AfroCentric shares relating to options or shares accepted in terms of the Company’s Share Option Scheme: Name of Director: Mr Hannes Boonzaaier Designation: Financial Director of Afrocentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 200 000 Price per security: R6.15 Value of transaction: R1 230 000.00 Clearance obtained: Yes Name of Director: Mr Billy Mokale Designation: Group Company Secretary Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 80 000 Price per security: R6.15 Value of transaction: R492 000.00 Clearance obtained: Yes Name of Director: Ms Nyathi Nomalungelo Designation: Executive Director: AfroCentric Health (Pty) Ltd – a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 150 000 Price per security: R6.15 Value of transaction: R922 500.00 Clearance obtained: Yes Name of Director: Mr Vijay Pillay Designation: Executive Director: AfroCentric Health (Pty) Ltd - a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 150 000 Price per security: R6.15 Value of transaction: R922 500.00 Clearance obtained: Yes Name of Director: Mr Anthony Pedersen Designation: Chief Executive Officer of Medscheme Holdings (Pty) Ltd - a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 200 000 Price per security: R6.15 Value of transaction: R1 230 000.00 Clearance obtained: Yes Name of Director: Ms Modjadji Tati Designation: Executive Director: AfroCentric Health (Pty) Ltd - a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 150 000 Price per security: R6.15 Value of transaction: R922 500.00 Clearance obtained: Yes Name of Director: Ms Grace Khoza Designation: Executive Director: AfroCentric Health (Pty) Ltd - a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 150 000 Price per security: R6.15 Value of transaction: R922 500.00 Clearance obtained: Yes Name of Director: Mr Aklaaq Mahmood Designation: Executive Director: AfroCentric Health (Pty) Ltd - a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 150 000 Price per security: R6.15 Value of transaction: R922 500.00 Clearance obtained: Yes Name of Director: Mr Lee Callakoppen Designation: Executive director of Medscheme Holdings (Pty) Ltd - a wholly owned subsidiary of AfroCentric Class of securities: Options in respect of ordinary shares Nature of interest: Direct beneficial Date of transaction: 22 November 2017 Nature of transaction: Acceptance of options granted in terms of the Company’s Share Option Scheme (Off - market trade) Date of expiry: 30 November 2019 Number of securities obtained: 150 000 Price per security: R6.15 Value of transaction: R922 500.00 Clearance obtained: Yes Johannesburg 23 February 2018 Sponsor: Sasfin Capital (a member of the Sasfin group) Date: 23/02/2018 05:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.